Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: A switch study

2006/06/11 by X WANG, Xiaofang Wang, R SAVAGE +15 · 1 citation
Medicine · Psychology · #Adverse effect #Antipsychotic #Atypical antipsychotic #Bipolar Disorder and Treatment #Clinical Global Impression #Discontinuation #Extrapyramidal symptoms #Internal medicine #Medicine #Obsessive-Compulsive Spectrum Disorders #Olanzapine #Placebo #Positive and Negative Syndrome Scale #Psychiatry #Psychology #Psychosis #Risperidone #Schizophrenia (object-oriented programming) #Schizophrenia research and treatment #Tolerability

paper · doi:10.1016/j.jpsychires.2006.03.008

openalex publication_date 2006/06/11 · crossref created 2006/06/11 · crossref issued 2006/10/01 · crossref published 2006/10/01 · crossref published-print 2006/10/01 · crossref deposited 2019/01/15 · openalex created_date 2025/10/10 · crossref indexed 2025/11/05 · openalex updated_date 2026/07/29

Citations

• The Effects of Risperidone on the Five Dimensions of Schizophrenia Derived by Factor Analysis
• Increased dopamine D 2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study
• Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials
• Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
• A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS

Cited by

• Thought disorder [wikipedia]